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to PTCA (n=63) or CABG (n=64). The primary end point of this study was to compare freedom 
from combined coronary cardiac events (death, myocardial infarction repeat revascularization 
procedures and angina) and late cost between both groups of patients at 1,3 and 5 years follow 
up. Results : At five years freedom from combined cardiac ewents was significantly greater in 
CABG than PTCA group (68% vs. 40% p < 0.001). However there were no differences in overall 
(9.4% vs. 12.7% p NS) and cardiac (6.8% vs. 6.8% p=NS) mortality and in the incidence of non 
fatal myocardial infarction (9.4% vs. 11.1% p = NS)between both groups. Patients with CABG had 
lower incidence of angina (27% vs. 46% p< 0.001), and required iess additional rernterventions 
(6.3 vs. 38% 0< 0.001) during follow up than patients with PTCA. Nevertheless, the prevalence 
of angina at the end of follow up was similar between CABG and PTCA patients (9.4% and 6.3% 
repesctlvely p = NS). Cumulative late cost at 5 years was greater for CABG than for PTCA group 
(US 832.000 vs. US 491.000 p <0.01). Conclusions: Patients with multiple vessel CAD treated 
with CABG were more frequently free from angina and need for new revascularization procedures 
than patients treated with PTCA. However, there were no difference in mortality and Incidence of 
non fatal myocardial infarction between both groups. Cumulative late cost was greater for CABG 
than PTCA group.
2543
Final Results in the Balloon vs Optimal Atherectomy Trial (BOAT): 6 Month 
Angiography and 1 Year Clinical Follow-up
Donald S Balm, Jeffrey J  Popma, Samln K Sharma, Richard Fortuna, Theodore L Schreiber, 
Cynthia Senerchia, Tia DeFeo-Fraulini, Donald E Cutllp, Kalon K Ho, Richard E Kuntz, The 
BOAT Investigators. Beth Israel Hospital, Boston MA USA, Washington Hospital Center, 
Washington DC USA, Mount Sinai Hospital, Hew York NY USA, Scripps Memorial Hospital, La 
Jolla CA USA
Between July 1994 and November 1995, the 38 participating BOAT centers enrolled 1,000 pts with 
focal de novo native coronary artery lesions, which were randomly assigned to either conventional 
balloon angioplasty or ‘optimal' directional atherectomy (in which the goal was to use a 7 Fr Athe- 
roCath, remove as much tissue as safely possible, and perform adjunctive balloon post-dilatation, 
to achieve a final residual diameter stenosis <20%). Acute results show that the DCA arm had 
higher lesion success (residual <50%, 98.8% vs 96.5%, p<0,05), lower use of 'bailout* catheter 
treatment (3.8% vs 9.6%, p<0.001), and higher procedural success (lesion success without a ma­
jor complication or ‘bailout" treatment, 93.2% vs 86.6%, p<0.005). The DCA arm also achieved 
a larger MLD (2.B2±0.50 vs 2.33±0.49 mm, p< 0.001) and a lower residual diameter stenosis 
(15± 13% vs 28±13%, p<0.001)» without an increase in the incidence of major complications 
(death, Q-MI, EmCABG; 2.8% vs 3.3%, p=NS). As expected from prior trials, however, DCA pts 
had a higher Incidence of CK-MB elevation >3x normal (14% vs 5%, p<0.001) In the setting of 
otherwise uncomplicated procedures. Six month angiographic follow-up Is expected to be complete 
by July 1996 with 1 year clinical follow-up complete by November 1996. This will determine whether 
the acute results o( larger lumens following atherectomy translate into reduced angiographic and/or 
clinical restenosis (measured as TSR, clinically-driven repeat revascularizatfons of the target site), 
whether there Is any Increase In late mortality risk (as suggested by CAVEAT), and whether there 
are any fate clinical consequences of post-procedurai CK elevation in pts with otherwise successful 
DCA or conventional angioplasty. Full data on these end-points will be presented.
2544
Outcomes and Their Predictors after PTCA in Patients with Type tl Diabetes 
Mellitus
Nancy L Hasslnger, Diane E Grill, David R Holmes, Jr.. Mayo C fe , ftoc/iesfer MN USA
Diabetic patients (DPs) frequently present for revascularization and account for 12-25% of pa­
tients in published clinical trials. Mortality may be higher in DPs after PTCA than CABG as seen 
in subgroup analysis of the BARI trial. This study examined 225 Type II (nonketotic) DPs who 
underwent PTCA between 1984-1994 at the Mayo Clinic matched to nonDPs for age, gender, 
degree ol disease, and dale of procedure. Results: DPs had a significantly higher prevafence of 
prior CABG (25 vs 14%)f HTN (66 vs 46%), CHF (23 vs 8%), and had lower ejection fractions 
(59 vs 63%) compared to nonDPs; unstable angina and history of Ml were not different. Technical 
success (95 vs 93%) and early (in hospital) complications of death and emergent CABG were sim­
ilar, Alter mean follow-up of 4 years there was no significant difference between DPs and nonDPs 
for myocardial Infarction, repeat intervention, or CABG. Mortality in DPs was higher: 17% vs 12% 
(p=0.048). Degree of control assessed as glycosylated hemoglobin (HA1C) at the time oi interven­
tion, correlated with late outcome. The relaiive risk of the combined endpoint death, Ml, or severe 
angina was 1.6 for HA 1C values >8.5 (p=0.038), there was no additional predictive strength when 
higher HA1C values were analyzed. Among DPs, those with a prior CABG were 2.1 times more 
likely to have a repeat intervention on a restenotic lesion; restenosis was lowest in those DPs 
taking an ACE Inhibitor as part of their overall therapy (odds ratio=0.32) Conclusions; 1) Despite 
having more co morbidities, percutaneous revascularization in DPs can achieve similar outcomes 
to nonDPs when age, gender, and degree of disease are considered. 2) Overall survival Is lower in 
diabetics. 3) Better diabetic control is associated with improved outcome. 4) ACE Inhibitor therapy 
may favorably Influence restenosis In DPs.
2545
The Role of Diabetes in Long-Term Survival After Coronary Bypass and 
Angioplasty
Gregory W Bareness, Eric D Peterson, E Magnus Ohman, Charlotte L Nelson, Robert M Callif. 
Puke University Medicai Center, Durham NC USA
Randomized trials have suggested that PTCA in diabetic patients with multivessel coronary dis­
ease results In higher mortality than CABG. To evaluate the effect of diabetes on outcome following 
revascularization in a large prospective cohort, we analyzed data on 3220 patients with symp­
tomatic 2- or 3-vessel coronary disease undergoing PTCA or CABG at Duke from 1984 to 1990. 
This group consisted of 704 PTCA patients, including 144 with diabetes (20.5%), and 2516 CABG 
patients, including 625 diabetics (24.8%). Patients with acute Infarction, prior revascularization, 
valvular or congenital disease, or significant left main disease were excluded. The mean followup
was 6,1 ±2.1 years. At 5 years, unadjusted survival in patients undergoing CABG was 74.3% in 
diabetics and 86.3% in non-diabetics. Likewise, 5-year survival in PTCA patients was 76.4% in 
diabetics and 88.3% in patients without diabetes. After adjusting for baseline risk factors includ­
ing age, gender, coronary anatomy, LVEF, mitral regurgitation and comorbidity, diabetic pallenis 
receiving either PTCA or CABG had significantly lower survival than non-diabetics (p<0,0001).
In contrast to previous studies, however, there was no significant differential effect of diabetes on 
outcome in patients treated with either PTCA or CABG (p> 0.3). Conclusion: While diabetes was 
a risk factor for worse long-term outcome in patients with multlvessel coronary artery disease, the 
effect was similar in the PTCA and CABG groups. These results do not support earlier conclusions 
that diabetes status should determine the choice of revascularization strategy.
2546
The Choice of Repeat CABG or PTCA in Diabetics Who Have had Previous 
CABG
William S Welntraub, Ellis L Jones, Joseph M Craver, Robert A Guyton, Douglas C Morris. 
Emory University, Atlanta GA USA
Outcome in 1041 diabetics with previous CABG was studied after repeat CABG (n=439) or PTCA 
(n=602). The PTCA group had more women (26% vs 21%), fewer prior Mis (56% vs 68), less 3 
vessel or left main disease (65% vs 81%) & higher EFs (51 vs 49). The groups were otherwise sim­
ilar. Hospital Q wave Mis occurred more often after (p) CABG (4,8% vs 2.2%), as did death (7*5% 
vs 2.0%). 5 & 10 year survival was 63% & 41 % p PTCA & 68% & 34% p CABG (left figure, p=NS).
5 & 10 year freedom from (FF) Ml was 71% & 56% p PTCA & 83% & 60% p CABG (p=0,01). 5 & 
10 year FF CABG was 70% & 53% p PTCA & 96% & 79% p CABG (p<0.0001). 5 & 10 year FF 
PTCA or CABG was 46% & 23% p PTCA & 91% & 47% p CABG (right figure, p<0.0001). Any sur­
vival difference between groups could be accounted for by the covariates age (OR 1.04 per year}, 
ejection fraction (OR 0,98 per % increase), time from prior CABG (OR 1.05 per year), heart failure 
(OR 1.71), hypertension (OR 1.40) and emergent or urgent procedure (OR 1.43 and 2,05)- Char­
acteristics, in-hospital and followup results and covariates in 284 PTCA & 262 CABG IR patients
were simitar. This study reveals that 
both long term death and non-fatal 
MI rates are high with either PTCA 
or repeat CABG. Thus, revascular­
ization choice in diabetics with pre­
vious CABG must be make without 
data to support a survival advan­
tage for either therapy, but rather 
on clinical, angiographic and patient 
preference grounds.
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2547
The Association Between a History of Diabetes and Outcome in Patients 
Undergoing Percutaneous Interventions
R. David Anderson, Nancy W. Wildermann, Robert A. Harrington, Gregory W, Bareness, David 
P. Faxon, E. Magnus Ohman. Duke University, Durham NC USA, Univ.of Southern California, 
Los Angeles CA USA
To study the relative importance of diabetes compared with other risk factors for adverse out­
comes (death, Ml, re-PTCA, CABG) after percutaneous intervention (PCI) we pooled data from 
7 multicenter trials. A total of 6338 pts with 6 to 9 mo clinical and angiographic follow-up were 
included. Diabetics were older (median age 62 v 59), less often male (63 v 78%), smoked less 
(64 v 74%), had more hypertension (68 v 45%), 3-vessel disease (11 v 6%), prior Ml (48 v 45%}. 
prior PTCA (20 v 15%), and prior CABG (23 v 14%). Diabetics and non-diabetics had similar 
pre-procedure stenosis (69 v 68%) and TIMl 3 flow (71 v 73%). Angiographic success (QCA < 
50%) and abrupt closure rates were similar between groups. Diabetics had higher 6 mo restenosis 
rates (49 v 44%p=0.04). Outcomes are shown in the table. Multivariable regression revealed lhat a 
history ol diabetes was associated with higher 9 mo composite outcomes after adjusting for base­
line variables (x 2=4.05 p=0.05) but prior Ml, 
_____________________________________pre-procedure stenosis, and # diseased ves-
No Diabetes Diabetes----sets were more predictive (x 2-69 p<.001). 
(n=5108) (n«1230)----Conclusion: Intermediate outcomes after PCI 
Death (30d) 27(0.5%) 14(1.2%)---- are best predicted by # diseased vessels, prior 
Composite (30d) 586(12%) 138(11%) and pre-procedure stenosis. Although &  
Death (9mo) 82(1.6%) 33(2,7%)----abetes Predicts composite outcomes, the el- 
Composite (9ma) 1600(33%) 439(38%)--- fect is and mostly due to higher restenosis 
  rates.
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After Successful Thrombolysisfor Acute Myocardial Infarction Culprit Lesion 
Morphology does Not Predict Early and Long-term Outcome.
Gerrit Veen, Care I C de Cock, Freek WA Verheugt. Free University Hospitaf, Amsterdam The 
Netherlands, University Hospital Radboud, Nijmegen The Netherlands
In the APRICOT-study we performed coronary angiography in 284 patients (pis) within 48 (mean 
24} hours after successful thrombolysis for acute myocardial infarction (AMI). Culprit lesion mor­
phology was scored as complex or smooth. After 3 months a second angiogram was performed in
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with complex morphology had more 
often multivessel disease (50% vs 
37%; p<0.05). The figure shows 
the 3-years follow-up for the com­
bined endpoint of death and recur­
rent Mi, showing no difference in 
outcome in relation to culprit lesion 
morphology. Conclusion: Complex 
morphology of a culprit coronary le­
sion early after successful throm­
bolysis for AMI is not associated 
with adverse outcome. Possibly re­
lated factors are lower reocclusion 
rate and higher Incidence of right 
coronary involvement.
2549
Fusion of Intracoronary Ultrasound and Biplane Angiography Images for 
Accurate 3D Reconstruction of Coronary Arteries
Robert M Cothren, Raj Shekhar, D G Vince, J F CornhilL Cleveland Clinic Foundation, 
Q&etantf OH USA, Ohio State University, Columbus OH USA
50 visualization of coronary morphology using intravascular ultrasound (IVUS) may aid tn eval­
uating atheroma progression and treatment efficacy. A method for accurate reconstruction of 
»fonary anatomy using IVUS and biplane fluoroscopy has been developed which depicts true 
arterial curvature and orientation, The IVUS transducer was tracked in time by back-projection 
ci biplane fluoroscopy during unassisted pullback in perfused non-atherosclerotic LADs ex vivo.
The luminal borders from simultaneously acquired IVUS images 
were placed perpendicular to the transducer path at each time 
point. Rotational orientation was determined by minimizing the 
mismatch between vessel outlines In angiograms and the re­
construction projected Into that plane. The result was surface- 
rendered for visualization or planimetry. Vessel curvature, lumen 
shape, and branch ostia could be easily visualized. Simulated an­
giograms created by projecting 3D reconstructions to 2D planes 
compared well with actual angiograms, with up to 71% overlap In 
lumen area, indicative ot the accuracy of the 3D representation. 
This technique does not depend upon automated pullback and 
constant-veloclty transducer movement, and does not assume 
the catheter to be straight, torsion-free, or centered in the lumen. 
This project will be extended to visualize luminal and adventlal 
surfaces in atherosclerotic arteries, and gated to visualize the 
vessel during the full cardiac cycle.
2550
A 3D Coronary Processing Tool to Optimize Visualization Strategy in the 
Cardiac Catheterization Laboratory
Shluh-Yung J. Chen, Kenneth R, Hoffman, John D. Carroll, University of Chicago, Chicago IL 
USA, University of Colorado, Denver CO USA
Due \o vessel overlap and foreshortening, multiple projections are necessary to adequately eval­
uate the coronary tree with arteriography. The traditional trial-and-error method provides views 
in which overlap and foreshortening are subjectively minimized in two dimension. A method has 
been dweioped for reconstructing a 3D coronary tree based on two views acquired from rou­
tine angiograms at arbitrary orientation. A computer simulation confirmed the accuracy of 3D 
vessel centerline reconstruction to within 2% error. Based on any coronary stenosis, a plane 
of gantry angulations minimizing the segment’s foreshortening is caculated yielding multiple 
computer-generated projection images. With this technique, the 3D structures and relationships 
of arteries can be clearly identified which are unable to be achieved by other modalities such
as intracoronary ultrasound or MRI. 
To date 3D reconstruction has been 
performed in 20 RCA, 16 LCA, and 
3 bypass grafts. With 3D coronary 
reconstruction, it is now possible to 
virtually determine ideal gantry po­
sitions. The assessment of lesion 
length and diameter narrowing can 
be optimized for both coronary Inter­
vention and studies of progression 
and regression.
Assessment of Coronary Artery morphology by Three-Dimensional 
Echocardiography
2551
Beruhard KoLsch, Susanne Mohr-Kakaiy, Thomas Meuzel, Stephan Waguer, Beate Kolfhaus, 
Thomas A. Fischer» Uwe Nlxdorff, Jargeu Meyer. Johannes Gulheberg - Universität, Maine 
Germany
The aim of the study was the quantitative assessment of left main coronary artery (LMCA), left 
circumflex artery (CX) and left anterior descending coronary artery (LAD) morphology using three- 
dmenslonal echocardiography. Results were compared to quantitative angiography. Method: The
three-dimensional data set was acquired using a multiplane transesophageal echocardiography- 
probe (Vingmed CFM 800 and multiplane probe, 5 MHz) by means of a TomTec 3D workstation. 
24 patients were examined (mean age 66 years). Results: In all 24 cases (100%) the accurate 
determination of the ostium of LMCA was possible (intraluminal diameter of the ostium: 1.1 - 
5.8mm, analysis of regression compared to angiography: r = 0.86). Visualization of LMCA was 
possible up to the point of bifurcation in 2 cases (length of LMCA was 2.54mm and 10.8mm, 
length of determinated LAD 8.1mm and 8.7mm, CX 3.2mm and 8.0mm), in 21 cases LMCA was 
visualized partially (6.1mm to '23.3mm, mean 9.5mm). In one case we found by means of 3D 
echocardiography that CX and LAD arose separately. Results were confirmed using angiography. 
CX could be reconstructed in 3 cases (length: 3.2mm - 8.0mm, mean 5.9mm, diameter 1.7 - 
3.1mm, correlation to angiography r = 0.86). LAD could also be determined in 3 cases (length 
8.0 - 8.7mm, mean 8.2mm, diameter 2.6 - 3.0mmr correlation to angiography r = 0.56). In one 
case we found a stenosis (lumen diameter 1.1mm) in the visible part of LMCA by means of 3D 
echocardiography whereas the angiographic examination showed a stenosis of 60% of this artery. 
In two cases with a blcuspide aortic valve it was possible to describe the exact origin of LMCA. In 
5 cases a three dimensional imaging of the aortic valve and the proximal part of the LMCA was 
possible to get an impression of the morphology of LMCA. Conc/us/ons : 3D echocardiography 
provides data about the morphology and the course of the proximal left coronary artery, with close 
correspondence to results obtained by angiography. U Improves the non invasive assessment of 
proximal coronary artery.
2552
Side Effects of Ionic Versus Nonionic Contrast Media in Cardiology 
(CIC-Study): A Multicenter Trail on 2690 Patients
Gerhard Hellige, Bernd Vogel, Ulrich Tebbe, Heinrich Kreuzer. Medical Faculty, Goettingen 
Germany
In behalf of the German Society of Cardiology and Cardiovasc. Res, a study was performed 
comparing the side effects of Ionic (I) and nonionic (Nl) contrast materials (CM) In elective car­
diography, Methods; The randomized double-blind study enrolled 2690 patients from 8 centers,
1350 received a monomeric ICM (Diatrizoate, Urografin^, Schenng), 1340 a monomeric NICM
(lopromid, Ultravistff, Schering). We documented anamnestic data like atopla, allergy, cardiac sta­
tus and medication as well as data on CM effects on hemodynamics, rhythm, creatinine and the 
incidenceof adverse reactions, complications and need of therapeutic interventions.The evaluation 
included logistic regression and calculation of odds ratios for risk factors (SASR), Results: Basic 
data of, the groups were not different, both received 121 ml CM. Major results are given in the ta­
ble. Odds ratios indicate risk/protective 
factors lor aliergoid reactions, dysp- 
noe, angina and bradycardia. Con elu­
sions: Mild and moderate adverse ef­
fects were reduced significantly by use 
of NICM whereas severe reactions re­
quiring major therapeutic interventions 
and thromboembolic complications oc­
curred very rarely after both CM with­
out significant differences.
Major data (% incidence) ICM NICM signif.
Arrhythmias, total 27.9 4,7 p<0.001
AV-Bloc, Asystole 5.1 0 p< 0.001
VT, Fibrillation 0.30 0.22 ns
Adverse reactions, total 14.4 4.5 p< 0.001
severe 0.67 0.45 ns
Thrombotic events (TIA,Ml) 0.37 0,37 ns
2553
Are Quantitative Angiographic Results After Coronary Intervention Affected by 
the Specific Analysis Algorithm?
Alexandra J  Lansky, Teraza Y Conway, Yan Zhang, Cynthia Senerchia, Nicole B Burwell, 
Shigenori Ito, Anthony B Pierre, Lahaina R Hall. Washington Hospital Center, Washington DC 
DC USA, Beth Israel Hospital, Boston MA USA, Harvard Medical Center, Boston MA USA
Binary angiographic restenosis rates after balloon angioplasty have varied substantially In new 
device restenosis trials (CAVEAT: 57%; Benestent: 33%), possibly due to differences in the an­
giographic algorithms (QCA) used in these studies. To assess the correlation between two QCA 
algorithms (Artrek; CMS-non GFT), we performed blinded, Identical frame QCA In 629 patients 
before, after, and late following coronary intervention, Pearson correlation (P Corr) Is reported (see 
Table). Between system differences in pre-MLD were highest In irregular lesions (0.16 mm versus 
0.12 mm In smooth lesions; p = 0.033). Acute gain (Artrek: 1,54 mm; CMS: 1.53 mm) and late 
loss (Artrek; 0.80 mm; CMS: 0.85 mm) were similar. No differences In restenosis rates (>50% 
follow-up stenosis) were identified (Artrek, 39% vs, CMS, 38%). Wa conclude that between-system 
QCA differences 1) are highest for pre-MLD, relating, In part, to lesion contour, but 2) do not appear 
to influence final angiographic results or late restanosls rates using these two systems.
N=629 Artrek CMS
Reference, mm 
MLD Pre, mm 
Final, mm 
Follow-up, mm 
%  Stenosis Pre 
Final
Foilow-up
tp<  0.001
3.07db0.40
0.92±0.32
2.46±0.51
1.67±0.70
69.9Ì9.8
20.7Ì14.0
44.4Ì2Z0
P-Corr Mean DifferenceiSD
3.22±0.45 0.92t 0.15i0.18f
1.05 db 0.35 0,81f 0.13±0.21t
2.58Ì0.55 0.92t 0.t1±0.22t
1.75±0.72 0.96f 0.08dfc0.19t
67.3db10.0 0.78t 2.7±6.6t
21.4±14.7 0.901 0.7±6.5t
44.0±21.4 0.95f 0.5±6.3t
2554
IMA- AND VEIN GRAFT PATENCY CONTROL BY ECHOCARDIOGRAPHY 
VERSUS THERMAL CORONARY ANGIOGRAPHY AS COMPARED DURING 
CORONARY BYPASS SURGERY.
James Likungu, Winfried Riitz, Paul G Klrchhoff. Department of Cardiovascular Surgery, Bonn 
Germany
The values of thermal coronary angiography (TCA) and echocardiography (E) for intraoperative 
assessment of coronary calcification, graft patency and flow in vein- and Internal mammary artery
